These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8734060)

  • 1. A numerical analysis of factor X activation in the presence of tissue factor--factor VIIa complex in a flow reactor.
    Gir S; Slack SM; Turitto VT
    Ann Biomed Eng; 1996; 24(3):394-9. PubMed ID: 8734060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.
    Repke D; Gemmell CH; Guha A; Turitto VT; Broze GJ; Nemerson Y
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7623-7. PubMed ID: 2120704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of shear rate on the enzymatic activity of the tissue factor-factor VIIa complex.
    Gemmell CH; Nemerson Y; Turitto V
    Microvasc Res; 1990 Nov; 40(3):327-40. PubMed ID: 2084499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow dependence of factor X activation by tissue factor-factor VIIa.
    Contino PB; Andree HA; Nemerson Y
    J Physiol Pharmacol; 1994 Mar; 45(1):81-90. PubMed ID: 8043911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational analysis of FXa generation by TF:FVIIa on the surface of rat vascular smooth muscle cells.
    Hall CL; Slack SM; Turitto VT
    Ann Biomed Eng; 1998; 26(1):28-36. PubMed ID: 10355548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport rate limited catalysis on macroscopic surfaces: the activation of factor X in a continuous flow enzyme reactor.
    Andree HA; Contino PB; Repke D; Gentry R; Nemerson Y
    Biochemistry; 1994 Apr; 33(14):4368-74. PubMed ID: 8155655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the kinetics of factor X activation by tissue factor-factor VIIA.
    Nemerson Y
    Haemostasis; 1996 Oct; 26 Suppl 4():98-101. PubMed ID: 8979116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions.
    Grabowski EF; Zuckerman DB; Nemerson Y
    Blood; 1993 Jun; 81(12):3265-70. PubMed ID: 8507863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the interaction of tissue factor/factor VII with factor X in a heterogeneous tubular reactor.
    Gemmell CH; Turitto VT; Nemerson Y
    Thromb Haemost; 1991 Feb; 65(2):139-43. PubMed ID: 2053099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor pathway inhibitor: a possible mechanism of action.
    Panteleev MA; Zarnitsina VI; Ataullakhanov FI
    Eur J Biochem; 2002 Apr; 269(8):2016-31. PubMed ID: 11985578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-mediated enzymatic reactions: simulations of tissue factor activation of factor X on a lipid surface.
    Gentry R; Ye L; Nemerson Y
    Biophys J; 1995 Aug; 69(2):362-71. PubMed ID: 8527649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor Xa generation at the surface of cultured rat vascular smooth muscle cells in an in vitro flow system.
    Hall CL; Taubman MB; Nemerson Y; Turitto VT
    J Biomech Eng; 1998 Aug; 120(4):484-90. PubMed ID: 10412419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.
    Bom VJ; Bertina RM
    Biochem J; 1990 Jan; 265(2):327-36. PubMed ID: 2302175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet agents affecting the interaction of Tissue Factor-Factor VIIa complex with Factor X in a continuous-flow reactor.
    Gir S; Reavis R; Turitto VT; Gollamudi R
    Biotechnol Appl Biochem; 1996 Feb; 23(1):63-6. PubMed ID: 8867897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.
    Gemmell CH; Broze GJ; Turitto VT; Nemerson Y
    Blood; 1990 Dec; 76(11):2266-71. PubMed ID: 2257300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin is a competitive inhibitor of the factor VIIa-tissue factor complex.
    Chabbat J; Porte P; Tellier M; Steinbuch M
    Thromb Res; 1993 Aug; 71(3):205-15. PubMed ID: 7692618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosite interactions determine the affinity of factor X for the extrinsic Xase complex.
    Baugh RJ; Dickinson CD; Ruf W; Krishnaswamy S
    J Biol Chem; 2000 Sep; 275(37):28826-33. PubMed ID: 10889208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.